Abstract

Neuromodulation

Obstet Gynecol Clin North Am. 2021 Sep;48(3):677-688.doi: 10.1016/j.ogc.2021.05.018.

Karen Noblett 1, Carly Crowder 2

 
     

Author information

  • 1Department of Obstetrics & Gynecology, University of California, Irvine, 101 The City Drive South, Orange, CA 92686, USA. Electronic address: knoblett@axonics.com.
  • 2Department of Obstetrics & Gynecology, University of California, Irvine, 101 The City Drive South, Orange, CA 92686, USA.

Abstract

Sacral neuromodulation (SNM) has been available in the United States for more than 20 years and is a guideline-recommended therapy by both the American Urological Association and the American Society of Colon and Rectal Surgeons, with proven long-term success for urinary urgency incontinence, urinary urgency frequency, nonobstructive urinary retention, and fecal incontinence. Initially the therapy involved a more invasive surgical approach that included a large cut down over the sacrum. This article reviews recent advancements in SNM therapy including updates in best practices for implant technique, technological innovations, and the new clinical literature relevant to contemporary practice.

© Copyright 2013-2022 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.